Global oncology innovation continues despite pandemic; global r&d pipeline reached 3,500 new drugs in 2020, up 75% from 2015, says new report from the iqvia institute for human data science

Research triangle park, n.c.--(business wire)--despite the substantial impact of the covid-19 pandemic on patient care during 2020, the scientific advances in oncology continued, with 3,500 new drugs in the pipeline in 2020, up 75 percent since 2015. oncologists worldwide report caseloads that are 26 to 51 percent lower than pre-pandemic levels, resulting in delays in necessary treatments. despite this, the surge in innovative cancer medicines continued, as reflected in clinical trial activity,
IQV Ratings Summary
IQV Quant Ranking